Cargando…

Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection

INTRODUCTION: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly emerged virus that poses a great threat to human health because of high fatality rate. METHODS: To develop sensitive and specific sero-diagnostic systems for SFTSV infections, monoclonal antibodies (MAbs) against reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mei, Du, Yanhua, Yang, Li, Zhan, Lin, Yang, Bin, Huang, Xueyong, Xu, Bianli, Morita, Koichi, Yu, Fuxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459026/
https://www.ncbi.nlm.nih.gov/pubmed/35835158
http://dx.doi.org/10.1016/j.bjid.2022.102386
_version_ 1784786411658936320
author Zhang, Mei
Du, Yanhua
Yang, Li
Zhan, Lin
Yang, Bin
Huang, Xueyong
Xu, Bianli
Morita, Koichi
Yu, Fuxun
author_facet Zhang, Mei
Du, Yanhua
Yang, Li
Zhan, Lin
Yang, Bin
Huang, Xueyong
Xu, Bianli
Morita, Koichi
Yu, Fuxun
author_sort Zhang, Mei
collection PubMed
description INTRODUCTION: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly emerged virus that poses a great threat to human health because of high fatality rate. METHODS: To develop sensitive and specific sero-diagnostic systems for SFTSV infections, monoclonal antibodies (MAbs) against recombinant SFTSV nucleocapsid (rSFTSV-N) protein were developed by immunizing BALB/C mice with rSFTSV-N protein and fusing the spleen cells with SP2/0 myeloma cells. Three hybridoma cell lines secreting MAbs against rSFTSV-N were obtained. MAb based IgG sandwich enzyme linked immunosorbent assay (ELISA) and IgM capture ELISA systems were established by using the newly developed MAbs. One hundred fifteen clinical suspected SFTS patients serum samples were used to evaluate the newly established systems by comparing with the total antibody detecting sandwich ELISA system and indirect ELISA systems. RESULTS: The MAbs based sandwich IgG ELISA was perfectly matched with that of the total antibody sandwich ELISA and the indirect IgG ELISA. IgM capture ELISA results perfectly matched with that of the total antibody sandwich ELISA while detecting eight additional positive samples missed by the indirect IgM ELISA. CONCLUSIONS: The MAbs against rSFTSV-N protein offer new tools for SFTSV studies and our newly developed MAb-based IgG and IgM capture ELISA systems would offer safe and useful tools for diagnosis of SFTS virus infections and epidemiological investigations.
format Online
Article
Text
id pubmed-9459026
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94590262022-09-10 Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection Zhang, Mei Du, Yanhua Yang, Li Zhan, Lin Yang, Bin Huang, Xueyong Xu, Bianli Morita, Koichi Yu, Fuxun Braz J Infect Dis Original Article INTRODUCTION: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly emerged virus that poses a great threat to human health because of high fatality rate. METHODS: To develop sensitive and specific sero-diagnostic systems for SFTSV infections, monoclonal antibodies (MAbs) against recombinant SFTSV nucleocapsid (rSFTSV-N) protein were developed by immunizing BALB/C mice with rSFTSV-N protein and fusing the spleen cells with SP2/0 myeloma cells. Three hybridoma cell lines secreting MAbs against rSFTSV-N were obtained. MAb based IgG sandwich enzyme linked immunosorbent assay (ELISA) and IgM capture ELISA systems were established by using the newly developed MAbs. One hundred fifteen clinical suspected SFTS patients serum samples were used to evaluate the newly established systems by comparing with the total antibody detecting sandwich ELISA system and indirect ELISA systems. RESULTS: The MAbs based sandwich IgG ELISA was perfectly matched with that of the total antibody sandwich ELISA and the indirect IgG ELISA. IgM capture ELISA results perfectly matched with that of the total antibody sandwich ELISA while detecting eight additional positive samples missed by the indirect IgM ELISA. CONCLUSIONS: The MAbs against rSFTSV-N protein offer new tools for SFTSV studies and our newly developed MAb-based IgG and IgM capture ELISA systems would offer safe and useful tools for diagnosis of SFTS virus infections and epidemiological investigations. Elsevier 2022-07-11 /pmc/articles/PMC9459026/ /pubmed/35835158 http://dx.doi.org/10.1016/j.bjid.2022.102386 Text en © 2022 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Zhang, Mei
Du, Yanhua
Yang, Li
Zhan, Lin
Yang, Bin
Huang, Xueyong
Xu, Bianli
Morita, Koichi
Yu, Fuxun
Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title_full Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title_fullStr Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title_full_unstemmed Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title_short Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
title_sort development of monoclonal antibody based igg and igm elisa for diagnosis of severe fever with thrombocytopenia syndrome virus infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459026/
https://www.ncbi.nlm.nih.gov/pubmed/35835158
http://dx.doi.org/10.1016/j.bjid.2022.102386
work_keys_str_mv AT zhangmei developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT duyanhua developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT yangli developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT zhanlin developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT yangbin developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT huangxueyong developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT xubianli developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT moritakoichi developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection
AT yufuxun developmentofmonoclonalantibodybasediggandigmelisafordiagnosisofseverefeverwiththrombocytopeniasyndromevirusinfection